Stay updated on Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial
Sign up to get notified when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.

Latest updates to the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedNew revision entry v3.5.0 added to the Record History and v3.4.3 removed.SummaryDifference0.1%

- Check26 days agoChange DetectedRecord history shows a new revision entry (v3.4.3) and removes the previous revision (v3.4.2).SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.4.2 has been added to the record history. The notice about government funding lapse and the previous Revision: v3.4.1 entry have been removed.SummaryDifference0.9%

- Check62 days agoChange DetectedA site-wide notice about a lapse in government funding was added. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.9%

- Check69 days agoChange DetectedThe Record History page now includes a Show glossary option, color-coded diff indicators for additions and deletions, and an updated revision label (v3.4.0).SummaryDifference1%

- Check83 days agoChange DetectedRevision v3.3.4 was added and Revision v3.3.3 was removed from the study's history.SummaryDifference0.1%

Stay in the know with updates to Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.